Bemis (BMS) Reports In-Line Q3 EPS; Guides a Touch Below the Street

Bemis (NYSE: BMS) reported Q3 EPS of $0.75, in-line with the analyst estimate of $0.75. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $1.06 billion.

GUIDANCE:

Bemis sees FY2016 EPS of $2.65-$2.70, versus the consensus of $2.72.

“Our key financial metrics improved this quarter,” said William F. Austen, Bemis Company's President and Chief Executive Officer. “Adjusted EPS increased nearly 12 percent over the prior year. We increased operating margins and delivered our highest total company EBITDA since 2014. Cash from operations improved sequentially, in line with our plan.” Austen continued, “We still have room for improvement. In our U.S. business, we planned for volume growth but disappointed ourselves with flat unit volumes this quarter. In our Global business, we continue to work on improving operational efficiencies at our expanded Oshkosh healthcare packaging facility and on executing our restructuring program in Latin America.” Austen further commented, “I remain confident in the long-term health of our business and remain committed to creating long-term shareholder value.”

For earnings history and earnings-related data on Bemis (BMS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c